SPORTS - Turbine™ » Turbine design complete and market ready; » Manufacturing partner secured; » Strong athlete endorsement & elite user trial; » Core target: males 20-50 years old across cycling, running, triathlons and aerobic sports initially; » A sophisticated international sports brand being built.
IN DEVELOPMENT - ROLLOUT 2014 & BEYOND
SLEEP– snoring & obstructive sleep apnea » Clear unmet needs; » Target males > 40 years plus; » Product design in progress for snoring & early stage sleep apnea; » Anticipated launch 2014.
WELLBEING – nasal congestion, appetite suppressant, yoga/pilates » Fragrance trial 2014; » Yoga & pilates product roll out in 2014.
DRUG DELIVERY – nasal medical delivery » Avoids current drug delivery issues; » Rapid uptake into blood stream; » Potential for patent extensions; » Potential treatment for sinus diseases and allergies; » First trial programme being defined – migraine.
IP & TECHNOLOGY • A nasal dilator with ability to adjust the dilation on each side; • Comfortable and discrete to wear; • Made of medical grade polymer; • Nasal breathing facilitates parasympathetic nervous system (reduces anxiety, slows heart rate and reduces muscle tension); • 18 patents granted & pending in major jurisdictions; • Trademarks granted & pending; • Global manufacturing partner secured for development in all areas
Clear milestones for next 6 months: • Deliver revenues with launch of sports product; the ‘Turbine’, November 2013; • Product development in snoring and well-being set for 2014 launch; • Clinical program: sleep apnea & drug delivery commence in 2014.
CGP Price at posting:
3.7¢ Sentiment: Buy Disclosure: Held
